Latest News and Press Releases
Want to stay updated on the latest news?
-
Starton Therapeutics’ Chief Executive Officer Chosen as 2024 Honoree by the Icla da Silva Foundation
PARAMUS, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with...
-
Successful feasibility study underscores compatibility of STAR-LLD using On-body Injector (OBI) technology and Starton’s proprietary low-dose formulation of lenalidomide (LLD)Based on the positive...
-
Scientific advisory board highly encouraged by STAR-LLD early Phase 1b data in multiple myelomaStrengthened the clinical strategy to focus on addressing major unmet medical needs and pursuing...